Cargando…
Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection
SARS-CoV-2, the newly emerged virus of the Coronaviridae family is causing havoc worldwide. The novel coronavirus 2019 was first reported in Wuhan, China marked as the third highly infectious pathogenic virus of the twenty-first century. The typical manifestations of COVID-19 include cough, sore thr...
Autores principales: | Kumar, Sonu, Dutta, Debrupa, Ravichandiran, Velayutham, Sukla, Soumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383686/ https://www.ncbi.nlm.nih.gov/pubmed/35982759 http://dx.doi.org/10.1007/s13205-022-03281-5 |
Ejemplares similares
-
In Vitro Anticancer Activity of Methanolic Extract of Justicia adhatoda Leaves with Special Emphasis on Human Breast Cancer Cell Line
por: Kumar, Sonu, et al.
Publicado: (2022) -
Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests
por: Nath, Himadri, et al.
Publicado: (2021) -
Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?
por: Nath, Himadri, et al.
Publicado: (2020) -
Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study
por: Singh, Rajveer, et al.
Publicado: (2020) -
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)